146 related articles for article (PubMed ID: 36524402)
21. A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma.
Saengwimol D; Rojanaporn D; Chaitankar V; Chittavanich P; Aroonroch R; Boontawon T; Thammachote W; Jinawath N; Hongeng S; Kaewkhaw R
Sci Rep; 2018 Oct; 8(1):15664. PubMed ID: 30353124
[TBL] [Abstract][Full Text] [Related]
22. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part II: Treatment Success and Globe Salvage.
Tomar AS; Finger PT; Gallie B; Mallipatna A; Kivelä TT; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E;
Ophthalmology; 2020 Dec; 127(12):1733-1746. PubMed ID: 32526306
[TBL] [Abstract][Full Text] [Related]
23. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
Sovinz P; Urban C; Lackner H; Benesch M; Langmann G
Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522
[TBL] [Abstract][Full Text] [Related]
24. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
[TBL] [Abstract][Full Text] [Related]
25. Exosomes: Insights from Retinoblastoma and Other Eye Cancers.
Lande K; Gupta J; Ranjan R; Kiran M; Torres Solis LF; Solís Herrera A; Aliev G; Karnati R
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992741
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines.
Stephan H; Boeloeni R; Eggert A; Bornfeld N; Schueler A
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3158-63. PubMed ID: 18579764
[TBL] [Abstract][Full Text] [Related]
27. Update on the Treatment of Retinoblastoma.
Manrique M; Akinbolue D; Madigan WP; Bregman J
Neoreviews; 2021 Jul; 22(7):e423-e437. PubMed ID: 34210807
[TBL] [Abstract][Full Text] [Related]
28. Update on intra-arterial chemotherapy for retinoblastoma.
Zanaty M; Barros G; Chalouhi N; Starke RM; Manasseh P; Tjoumakaris SI; Shields CL; Hasan D; Bulsara K; Rosenwasser RH; Jabbour P
ScientificWorldJournal; 2014; 2014():869604. PubMed ID: 25405236
[TBL] [Abstract][Full Text] [Related]
29. The rb pathway and cancer therapeutics.
Du W; Searle JS
Curr Drug Targets; 2009 Jul; 10(7):581-9. PubMed ID: 19601762
[TBL] [Abstract][Full Text] [Related]
30. EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy.
Mitra M; Kandalam M; Harilal A; Verma RS; Krishnan UM; Swaminathan S; Krishnakumar S
Mol Vis; 2012; 18():290-308. PubMed ID: 22328825
[TBL] [Abstract][Full Text] [Related]
31. Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity".
Munier FL; Beck-Popovic M; Chantada GL; Cobrinik D; Kivelä TT; Lohmann D; Maeder P; Moll AC; Carcaboso AM; Moulin A; Schaiquevich P; Bergin C; Dyson PJ; Houghton S; Puccinelli F; Vial Y; Gaillard MC; Stathopoulos C
Prog Retin Eye Res; 2019 Nov; 73():100764. PubMed ID: 31173880
[TBL] [Abstract][Full Text] [Related]
32. Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma.
Soliman SE; Dimaras H; Souka AA; Ashry MH; Gallie BL
J Fr Ophtalmol; 2015 Jun; 38(6):550-8. PubMed ID: 25982424
[TBL] [Abstract][Full Text] [Related]
33. Targeting HSP90/Survivin using a cell permeable structure based peptido-mimetic shepherdin in retinoblastoma.
Venkatesan N; Kanwar JR; Deepa PR; Navaneethakrishnan S; Joseph C; Krishnakumar S
Chem Biol Interact; 2016 May; 252():141-9. PubMed ID: 27062892
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
Berry JL; Shah S; Bechtold M; Zolfaghari E; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
[TBL] [Abstract][Full Text] [Related]
35. Retinoblastoma--a clinico-pathological study in Ilorin, Nigeria.
Owoeye JF; Afolayan EA; Ademola-Popoola DS
Afr J Health Sci; 2006; 13(1-2):117-23. PubMed ID: 17348751
[TBL] [Abstract][Full Text] [Related]
36. Recent advances and challenges in the management of retinoblastoma.
Chawla B; Singh R
Indian J Ophthalmol; 2017 Feb; 65(2):133-139. PubMed ID: 28345569
[TBL] [Abstract][Full Text] [Related]
37. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
[TBL] [Abstract][Full Text] [Related]
38. Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome.
Russo I; Levy-Gabriel C; Dupont A; Lumbroso-Le Rouic L; Cassoux N; Desjardins L; Bertozzi AI; Coze C; Doz F; Savignoni A; Aerts I
Pediatr Blood Cancer; 2021 Jan; 68(1):e28721. PubMed ID: 33098751
[TBL] [Abstract][Full Text] [Related]
39. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
[TBL] [Abstract][Full Text] [Related]
40. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.
Shields CL; Bas Z; Tadepalli S; Dalvin LA; Rao R; Schwendeman R; Lally SE; Shields JA; Shah A; Leahey A
Br J Ophthalmol; 2020 Nov; 104(11):1548-1555. PubMed ID: 32051141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
